RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Spectrum Pharmaceuticals Presents Data at the AACR-NCI-EORTC Meeting That SPI-1620 Significantly Enhances the Anti-Tumor Efficacy of Paclitaxel in Breast Tumor Model

Spectrum Pharmaceuticals Presents Data at the AACR-NCI-EORTC Meeting That SPI-1620 Significantly Enhances the Anti-Tumor Efficacy of Paclitaxel in Breast Tumor Model

18th Nov 2005, 18:43 GMT

* Data is published in the current edition of a peer-reviewed journal, Breast Cancer Research and Treatment

View full story at www.myhealthcarenews.com

Spectrum Pharmaceuticals Presents Data at the AACR-NCI-EORTC Meeting That SPI-1620 Significantly Enhances the Anti-Tumor Efficacy of Paclitaxel in Breast Tumor Model related news:

Latest news from Radiology News from StratCenter.com: